CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-24 | Lewis Michael Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2015-06-24 | JOHNSON JOHN Director | Grant or award · Stock Option (Right to Buy) | +10,475 | 10,475 | ||
| 2015-06-24 | RAKIN KEVIN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2015-06-24 | Baltzell Joshua J Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2015-06-24 | Kong Garheng Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2015-06-01 | Lewis Michael Director | Other disposition | −89,441 | 1,827,666 | ||
| 2015-06-01 | Wilmslow Estates Ltd 10% owner | Other disposition | −89,441 | 1,827,666 | ||
| 2015-02-26 | McArdle Kevin Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2015-02-26 | McArdle Kevin Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2015-02-26 | Gridley Adam See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +104,000 | 104,000 | ||
| 2015-02-26 | Gridley Adam See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2015-02-26 | Kennedy Stephen Richard SVP of Technical Operations | Grant or award · Employee Stock Option (Right to Buy) | +49,100 | 49,100 | ||
| 2015-02-26 | Kennedy Stephen Richard SVP of Technical Operations | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2015-02-02 | GILL DAVID N Director | Grant or award · Employee Stock Option (Right to Buy) | +13,200 | 13,200 | ||
| 2014-12-08 | Sofinnova Venture Partners VIII, L.P. 10% owner | Conversion | +960,345 | 960,345 | ||
| 2014-12-08 | Sofinnova Venture Partners VIII, L.P. 10% owner | Conversion | +611,738 | 1,572,083 | ||
| 2014-12-08 | Sofinnova Venture Partners VIII, L.P. 10% owner | Option exercise | +14,569 | $0.76 | $11K | 1,586,652 |
| 2014-12-08 | Sofinnova Venture Partners VIII, L.P. 10% owner | Sale | −1,002 | $11.00 | $11K | 1,585,650 |
| 2014-12-08 | Sofinnova Venture Partners VIII, L.P. 10% owner | Purchase | +500,198 | $11.00 | $5.5M | 2,085,848 |
| 2014-12-08 | Sofinnova Venture Partners VIII, L.P. 10% owner | Other disposition | −8,808 | 2,077,040 |
Page 24 of 27 · 525 trades